Secondly, PD-L1 status may change as a result of prior chemotherapy, and thirdly, PD-L1 status may be heterogeneous throughout the tumour, such intratumoural heterogeneity of biomarker expression is well documented in gastric cancer patients [31]. The gene discussed is CD274; the disease is gastric cancer.